Hinge Health
Hinge Health is a digital clinic for joint and muscle care. Its app pairs exercise therapy with access to physical therapists, health coaches and physicians, and it sells Enso, an FDA-cleared wearable for drug-free pain relief. The company sells to employers and health plans, and has extended beyond musculoskeletal care into pelvic health and migraine care. It has traded on the New York Stock Exchange under the ticker HNGE since May 2025.
Public Company
Hinge Health is publicly traded
IPO'd on May 22, 2025
This company is no longer available on our private secondary market. Shares can be traded publicly under HNGE.
Overview
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2014
Employees
1,001–5,000
Total Funding
$1.46B
8 rounds
Last Private Valuation
$6.2B
Oct 28, 2021
Secondary Signals (Note: SetterVC does not verify the accuracy of these)
1 signalSigned definitive agreement to acquire Cylinder Health for $105M cash, expanding into gastrointestinal care
Strategic expansion beyond MSK; new clinical category could support future valuation upside
Funding
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $1.46B across 8 rounds
Last updated 09-03-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| May 22, 2025 | IPO TechCrunch | $437.3M | $3B | Public markets |
| Oct 28, 2021 | Series E Bloomberg | $400M | $6.2B | Tiger Global, Coatue |
| Oct 28, 2021 | Secondary | $200M | $6.2B | Tiger Global, Coatue |
Valuation Trajectory
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Entry · Series D
$3B
Jan 2021
Hinge Health today
$3B
May 2025 · latest mark
Hinge Health multiple
1.0x
valuation uplift since first round
Y-axis is logarithmic. Hollow dots = estimated valuations. Does not represent realized investor returns.
Prominent Investors
Leadership
Daniel Perez
Chief Executive Officer & Co-Founder
Gabriel Mecklenburg
Executive Chairman & Co-Founder
Lex Annison
Chief Operating Officer
James Budge
Chief Financial Officer
Lalith Vadlamannati
Chief Technology Officer
Jeff Krauss
Chief Medical Officer
Competitors
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Sword Health
Digital MSK care platform providing AI-powered therapy and clinical support
Wavi
Digital physical therapy platform with wearable integration
Ro
Digital healthcare platform offering various telehealth services
Hinge Health Investment FAQ
Hinge Health FAQ
Yes, Hinge Health is publicly traded under the ticker symbol HNGE on the NYSE. The company went public in May 22, 2025.
Hinge Health trades under the ticker symbol HNGE on the NYSE. It began trading in May 22, 2025.
Hinge Health (HNGE on the NYSE) shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker HNGE to place an order.
Hinge Health went public in May 22, 2025 via ipo, with an offering valuation of approximately $6.2B. Hinge Health completed its IPO on NYSE on May 22, 2025, under ticker HNGE. The company priced shares at $32 per share, raising approximately $437.3 million (9.14M shares). Opening price was $39.25, closing at $37.56 for a market cap exceeding $3 billion.
Hinge Health raised $1.46B across 8 disclosed funding rounds prior to its public listing.
Hinge Health was co-founded by Daniel Perez, and Gabriel Mecklenburg in 2014.
Hinge Health is headquartered in San Francisco, California, US.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.